Potential Method for Treating Scleroderma Uncovered

Researchers have discovered a potential approach for reversing the damage associated with scleroderma. Researchers at the Hospital for Special Surgery in New York City have uncovered a potential method for slowing skin fibrosis for patients with scleroderma. Scleroderma is an autoimmune disease characterized by chronic inflammation in fibrotic tissue below the skin. In a study published in the Journal of Clinical Investigation, researchers used stem cells called adipose-derived stromal cells, or ADSCs, to test how the characteristic erosion of skin occurs during scleroderma.